CLINICAL_TRIALS
trial_result
· 2021-11-01
Clinical Trial Update: Safety and Efficacy of Secukinumab in Mild Psoriasis [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of secukinumab in mild psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: James G. Krueger, MD, PhD | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2021-11-01